PDL2 and MGL2 have been identified on CD11c+CD11b+ cells in a metastatic tumor-released GM-CSF microenvironment and implicated in the suppression of CD8 T-cells and the expansion of Tregs, respectively52. The gene discussed is CSF2; the disease is metastatic neoplasm.